SG11201605498VA - Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib - Google Patents

Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib

Info

Publication number
SG11201605498VA
SG11201605498VA SG11201605498VA SG11201605498VA SG11201605498VA SG 11201605498V A SG11201605498V A SG 11201605498VA SG 11201605498V A SG11201605498V A SG 11201605498VA SG 11201605498V A SG11201605498V A SG 11201605498VA SG 11201605498V A SG11201605498V A SG 11201605498VA
Authority
SG
Singapore
Prior art keywords
derivate
gefitinib
pyridazine
dihydro
oxo
Prior art date
Application number
SG11201605498VA
Other languages
English (en)
Inventor
Friedhelm Bladt
Manja Friese-Hamim
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SG11201605498VA publication Critical patent/SG11201605498VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201605498VA 2014-01-07 2014-12-16 Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib SG11201605498VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14000035 2014-01-07
PCT/EP2014/003366 WO2015104043A1 (en) 2014-01-07 2014-12-16 Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib

Publications (1)

Publication Number Publication Date
SG11201605498VA true SG11201605498VA (en) 2016-08-30

Family

ID=49916968

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201605498VA SG11201605498VA (en) 2014-01-07 2014-12-16 Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib

Country Status (16)

Country Link
US (1) US20160324855A1 (es)
EP (1) EP3091979A1 (es)
JP (1) JP2017502055A (es)
KR (1) KR20160106147A (es)
CN (1) CN105848658A (es)
AR (1) AR099036A1 (es)
AU (1) AU2014377080A1 (es)
CA (1) CA2935892C (es)
CL (1) CL2016001727A1 (es)
IL (1) IL246629A0 (es)
MX (1) MX2016008816A (es)
PH (1) PH12016500948A1 (es)
RU (1) RU2016132400A (es)
SG (1) SG11201605498VA (es)
TW (1) TW201609102A (es)
WO (1) WO2015104043A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3039401B1 (fr) * 2015-07-31 2018-07-13 Les Laboratoires Servier Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr
KR20200077193A (ko) 2018-12-20 2020-06-30 노수민 드론의 항공사진촬영을 활용한 농지법 위반 단속

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007032507A1 (de) * 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
BR112014022266A2 (pt) * 2012-03-19 2021-09-08 Merck Patent Gmbh Combinação de um derivado de 6-oxo-1,6-di-hidro-piridazina tendo atividade anticâncer com outros compostos antitumor
CN104245701A (zh) * 2012-04-03 2014-12-24 诺华有限公司 有酪氨酸激酶抑制剂的组合产品和其应用

Also Published As

Publication number Publication date
TW201609102A (zh) 2016-03-16
RU2016132400A3 (es) 2018-07-04
IL246629A0 (en) 2016-08-31
WO2015104043A1 (en) 2015-07-16
EP3091979A1 (en) 2016-11-16
CL2016001727A1 (es) 2016-12-16
KR20160106147A (ko) 2016-09-09
RU2016132400A (ru) 2018-02-13
CA2935892A1 (en) 2015-07-16
CA2935892C (en) 2022-08-02
JP2017502055A (ja) 2017-01-19
AU2014377080A1 (en) 2016-08-18
CN105848658A (zh) 2016-08-10
MX2016008816A (es) 2016-09-08
US20160324855A1 (en) 2016-11-10
AR099036A1 (es) 2016-06-22
PH12016500948A1 (en) 2016-06-27

Similar Documents

Publication Publication Date Title
IL273591A (en) Picolinamide compounds have fungicidal activity
ZA201704555B (en) Picolinamide compounds with fungicidal activity
ZA201704560B (en) Picolinamide compounds with fungicidal activity
GB2525285B (en) Catalyst arrangement
LT3094593T (lt) Anglies mikrogamykla
SG11201700233XA (en) Catalysts
HK1217083A1 (zh) 活動監視器
AU360060S (en) Lighter
GB201415846D0 (en) Catalyst
SG11201606414QA (en) Catalyst
IL249511B (en) Novel p450–bm3 variants with enhanced activity
EP3146495A4 (en) Generating activity summaries
SG11201703623SA (en) Catalysts
HK1246264A1 (zh) 催化燃燒器設備
IL256441B (en) New p450–bm3 variants with enhanced activity
ZA201701901B (en) Catalyst with improved hydrothermal stability
ZA201704621B (en) Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with a quinazoline derivative
ZA201704654B (en) Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with an egfr inhibitor
SG11201605498VA (en) Combination of a 6-oxo- 1,6-dihydro-pyridazine derivate having anti-cancer activity with gefitinib
IL230676A0 (en) Pocket-shaped bread
HK1217360A1 (zh) 火撐子
SG11201704507YA (en) Rivet
LT3034942T (lt) Biologinės alyvos degiklis su alyvos antgaliu
GB201420213D0 (en) Catalysts
GB201412992D0 (en) Catalysts